Hier de balance sheet en de cashpositie. Misschien maakt dat het duidelijk?
Cash and cash equivalents 2,087,797 5,599,787 2,087,797 5,599,787 1,861,616
Current financial investments 3,220,805 - 3,220,805 - 3,919,216
R&D incentives receivables 122,878 99,711 122,878 99,711 115,356
Assets 5,721,086 5,851,752 5,721,086 5,851,752 6,068,609
Shareholders' equity 2,712,082 2,535,281 2,712,082 2,535,281 2,875,658
Deferred income 2,789,183 3,127,777 2,789,183 3,127,777 3,000,646
Other liabilities 219,821 188,695 219,821 188,695 192,305
Current financial investments at end of the period 3,220,805 - 3,220,805 - 3,919,216
Total current financial investments and cash and cash equivalents at end of the period 5,308,602 5,599,787 5,308,602 5,599,787 5,780,832